Perigon Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$887K Sell
1,579
-17
-1% -$10.9K 0.02% 569
2025
Q4
$1.08M Buy
1,596
+67
+4% +$45.6K 0.02% 519
2025
Q3
$977K Buy
1,529
+71
+5% +$43.1K 0.02% 518
2025
Q2
$782K Buy
1,458
+45
+3% +$21.5K 0.02% 543
2025
Q1
$593K Sell
1,413
-61
-4% -$26.5K 0.02% 590
2024
Q4
$632K Buy
1,474
+26
+2% +$11.4K 0.02% 575
2024
Q3
$732K Sell
1,448
-6
-0.4% -$2.92K 0.02% 512
2024
Q2
$708K Buy
1,454
+56
+4% +$28.1K 0.02% 451
2024
Q1
$755K Buy
1,398
+14
+1% +$7.65K 0.02% 437
2023
Q4
$768K Buy
1,384
+891
+181% +$418K 0.03% 401
2023
Q3
$216K Buy
+493
New +$246K 0.01% 709
2021
Q1
Sell
-45
Closed -$22K 741
2020
Q4
$22K Buy
+45
New +$20.1K ﹤0.01% 1009

Other funds holding IDXX

Perigon Wealth Management's IDXX Position: Q1 2026 in Review

Perigon Wealth Management reduced its Idexx Laboratories (IDXX) stake by 1.1% in Q1 2026, selling an estimated $10.9K and leaving 1,579 shares worth $887K. The position accounts for 0.02% of the portfolio, ranked #569.

Perigon Wealth Management first reported a position in IDXX in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.08M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Perigon Wealth Management held 1,579 shares of Idexx Laboratories worth $887K as of Q1 2026.
  • Perigon Wealth Management sold 17 Idexx Laboratories shares in Q1 2026, an estimated $10.9K.
  • Idexx Laboratories made up 0.02% of Perigon Wealth Management's portfolio in Q1 2026, its #569 holding.
  • Perigon Wealth Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 12 quarters since.
  • Perigon Wealth Management's Idexx Laboratories position peaked at $1.08M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.